Gene · 10549
Papers1,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Altered expression of MZB1 in periodontitis: A possible link to disease pathogenesis. | J Periodontol | 2023 | 37332260 | PubTator, text mining | PubMed |
| Integrative proteomics, phosphoproteomics and acetylation proteomics analyses of acute pancreatitis in rats. | Int J Med Sci | 2023 | 37324185 | PubTator, text mining | PubMed |
| High-resolution structural-omics of human liver enzymes. | Cell Rep | 2023 | 37289586 | PubTator, text mining | PubMed |
| Cytotoxic properties of unfractionated and fractionated bromelain alone or in combination with chemotherapeutic agents in colorectal cancer cells. | PLoS One | 2023 | 37262048 | PubTator, text mining | PubMed |
| Protective Effects of H2S Donor Treatment in Experimental Colitis: A Focus on Antioxidants. | Antioxidants (Basel) | 2023 | 37237891 | PubTator, text mining | PubMed |
| Peroxiredoxin 2: An Important Element of the Antioxidant Defense of the Erythrocyte. | Antioxidants (Basel) | 2023 | 37237878 | PubTator, text mining | PubMed |
| Unfolding the Interactions between Endoplasmic Reticulum Stress and Oxidative Stress. | Antioxidants (Basel) | 2023 | 37237847 | PubTator, text mining | PubMed |
| The Role of Peroxiredoxins in Cancer Development. | Biology (Basel) | 2023 | 37237480 | PubTator, text mining | PubMed |
| Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome. | Signal Transduct Target Ther | 2023 | 37230968 | PubTator, text mining | PubMed |
| Proteomic Analysis of Mesenchymal Stem Cells and Monocyte Co-Cultures Exposed to a Bioactive Silica-Based Sol-Gel Coating. | ACS Biomater Sci Eng | 2023 | 37202924 | PubTator, text mining | PubMed |
| Overexpression of GREM1 Improves the Survival Capacity of Aged Cardiac Mesenchymal Progenitor Cells via Upregulation of the ERK/NRF2-Associated Antioxidant Signal Pathway. | Cells | 2023 | 37190112 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Redox Systems and Polyamine Metabolic Pathway in Hepatoma and Non-Tumor Hepatocyte-like Cells. | Biomolecules | 2023 | 37189460 | PubTator, text mining | PubMed |
| Metal Nanoparticle-Flavonoid Connections: Synthesis, Physicochemical and Biological Properties, as Well as Potential Applications in Medicine. | Nanomaterials (Basel) | 2023 | 37177076 | PubTator, text mining | PubMed |
| Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration. | Sci Rep | 2023 | 37173373 | PubTator, text mining | PubMed |
| Rise and fall of peroxisomes during Alzheimer´s disease: a pilot study in human brains. | Acta Neuropathol Commun | 2023 | 37170361 | PubTator, text mining | PubMed |
| Zinc homeostasis governed by Golgi-resident ZnT family members regulates ERp44-mediated proteostasis at the ER-Golgi interface. | Nat Commun | 2023 | 37160917 | PubTator, text mining | PubMed |
| Proteome changes in a human retinal pigment epithelial cell line during oxidative stress and following antioxidant treatment. | Front Immunol | 2023 | 37153596 | PubTator, text mining | PubMed |
| Reduction of Paraoxonase Expression Followed by Inactivation across Independent Semiaquatic Mammals Suggests Stepwise Path to Pseudogenization. | Mol Biol Evol | 2023 | 37146172 | PubTator, text mining | PubMed |
| Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis. | Chin Med J (Engl) | 2023 | 37130223 | PubTator, text mining | PubMed |
| Breast cancer cell secretome analysis to decipher miRNA regulating the tumor microenvironment and discover potential biomarkers. | Heliyon | 2023 | 37128318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10549/papers?page=8